Clinical significance of the expression levels of serum transforming growth factor-β and CXC type chemokine ligand 13 in primary Sjogren’s syndrome patients

被引:0
作者
Jing He
Changsong Xu
Yamei Zhu
Meimei Xu
Yueyue Chen
Liang Guo
Zhengyue Jing
Bo Xu
Suling Wu
机构
[1] Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine,Department of Immunology and Rheumatology
来源
Clinical Rheumatology | 2023年 / 42卷
关键词
CXCL13; Effective indicator; pSS; TGF-β1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3283 / 3288
页数:5
相关论文
共 44 条
[1]  
Tomiak C(2006)Sjogren’s syndrome. Current aspects from a rheumatological point of view Z Rheumatol 65 505-517
[2]  
Dorner T(2015)Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis Ann Rheum Dis 74 1983-1989
[3]  
Qin B(2010)Epidemiology of primary Sjogren’s syndrome Z Rheumatol 69 41-49
[4]  
Wang J(2020)IL-6 contributes to the TGF-β1-mediated epithelial to mesenchymal transition in human salivary gland epithelial cells Arch Immunol Ther Exp 68 27-156
[5]  
Yang Z(2023)The wound-healing activity of PEDOT-PSS in animals Int J Mol Sci 24 12539-1601
[6]  
Westhoff G(2016)Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations Expert Rev Clin Immunol 12 137-31
[7]  
Zink A(2008)Oral involvement in primary Sjögren syndrome J Am Dent Assoc 139 1592-295
[8]  
Margherita S(2014)Rethinking dry eye disease: a perspective on clinical implications Ocul Surf 12 1-287
[9]  
Roberto T(2011)Risk factors and symptoms associated with xerostomia: a cross-sectional study Aust Dent J 56 290-331
[10]  
Domenico R(2015)The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review Clin Rev Allergy Immunol 49 278-26